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Abstract: Malaria still claims a heavy human and economic toll, specifically in sub-Saharan 
Africa. Even though the causality between malaria and poverty is presumably bi-directional, 
malaria plays a role in the economic difficulties of the region. This article provides an analysis of 
the economic consequences of malaria (with an emphasis on human capital accumulation and 
productivity), and a discussion of policies aimed at reducing its incidence. A major initiative has 
been the distribution of insecticidal bed-nets at a highly subsidized price. An economic-
epidemiology model is used to explain why such policy is doomed to fail in presence of a very 
high poverty incidence, as observed in the African region. 
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1 Introduction 
Malaria is prevalent throughout most of the tropical world.  In 2010,  approximately 2.57 billion 
people lived in regions of the world at risk of P. falciparum transmission (798.42 million in Africa, 
Gething et al. 2011) and 2.85 billion people were exposed to some risk of P. vivax transmission in 
2009 (98 million in Africa, Guerra et al. 2010). There were an estimated 1,238,000 million malaria 
deaths worldwide in 2010 (1,133,000 in Africa, Murray et al. 2012). Malaria is considered one of 
the most common infectious diseases and the most influential of the parasitic diseases.1 
Furthermore, there is currently no vaccine against the parasite. 
 
Malaria is also more than merely a tropical disease that claims a heavy toll on lives in sub-Saharan 
Africa (SSA) and is economically costly. In recent debates among development economists, 
malaria has been at the center of a controversy about the causality between health and economic 
performances. This relation is probably bidirectional but economic analyses on the cost of 
malaria in Africa have contributed to this important debate.  
 
In the context of Millennium Development Goals (MDGs), major efforts have been devoted to 
the fight against malaria. A variety of prevention and treatment measures have been put in place. 
The cost effectiveness of malaria prevention and treatment tools that have been used in malaria 
control strategies are in principle very high in experimental contexts. However, large-scale results 
of impact evaluations of anti-malaria campaigns are not always as positive as they might be. 
Malaria continues to be a significant cause of global mortality and morbidity. Indeed, despite the 
recent decreasing trend in malaria mortality and morbidity in Africa and a renewed optimism, it 
is still difficult to disentangle the complementary causal effects of existing strategies: net 
distribution; distribution of new antimalarial drugs—artemisinin combination therapies (ACTs); 
and insecticide spraying.  
 
Numerous examples could be given and are illustrative. First, in spite of massive efforts to 
generalize efficient prevention, such as insecticide-treated mosquito nets (ITNs) or long-lasting 
insecticidal nets (LLINs), ITN coverage remains low in large populations at risk despite rapid 
increase, and ITN are still only used to a limited extent (Flaxman et al. 2010). A second example 
resides in the controverted results of the Affordable Medicines Facility-malaria (AMFm) 
programme, a sustained global subsidy of ACTs (Arrow 2004). A last example is related to 
national malaria control programmes’ official policies and results. Van Eijk et al. (2011) 
synthesise data from national surveys and conclude that coverage of ITNs and intermittent 
preventive treatment (IPT) in pregnant African women is inadequate despite the fact that 45 of 
the 47 countries surveyed had a policy for distribution of ITNs for pregnant women and 39 had 
an intermittent preventive treatment policy. These results suggest a need for a deeper economic 
analysis combined with epidemiological tools that recognizes the complex character of malaria. 
This is all the more feasible in 2013, contrary to 10 years ago, because part of the information 
                                                
1 Most of infections in humans are caused by four different species of the genus Plasmodium. Plasmodium falciparum, 
Plasmodium malariae, Plasmodium vivax, and Plasmodium ovale are associated with different clinical presentations, 
progression, prevalence, and antimalarial resistance patterns. Recently human malaria cases due to P. knowlesi have 
been detected (Singh and Daneshvar 2013). P. falciparum infection results in the highest morbidity and mortality, 
accounting for almost all of the over one million deaths caused by malaria annually, most of them in young children 
in Africa. The incidence of malaria is defined as the number of new cases of malaria for a given population during a 
specific time period (given in person-time). The prevalence of malaria is defined as the total number of malaria cases in 
a given population at a specific time. 
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gap on malaria morbidity could be filled with the growing number of large scale malaria indicator 
surveys.  
 
In addition, the analysis of Arrow (2004) suggests that ‘insecticide-treated bed nets and other, 
broad environmental strategies offer great potential for synergy when effective drug therapies are 
available’. Indeed, it would be necessary to identify the optimal combination of strategies for 
action in an integrated way, given the risk of development of ACT-resistant Plasmodium falciparum 
malaria parasites  
 
This paper is organized as follows: The next section provides a description of malaria control 
strategies that have been implemented in Africa. Section 3 gives an overview of economic 
methods used for estimating the economic impact of Malaria in Africa and estimating malaria 
costs, taking into account the endogenous relationship between malaria and economic 
development. Section 4 presents a malaria economic epidemiology model, aiming at explaining 
why under some circumstances policies of dissemination of protection devices cannot eradicate 
malaria; such circumstances are in particular related to situations where the poverty incidence is 
high. Section 5 concludes.  
 
2 Malaria control strategies in Africa: an overview 
2.1 Recent history of malaria control in Africa 
Figure 1 provides a very schematic history of malaria control since 1900. There is evidence that 
the World Health Organization (WHO) global initiative to fight malaria launched in the 1950s 
has been much more effective in Asia than in Africa. The emergence and spread of chloroquine-
resistant Plasmodium falciparum malaria parasites has been a disaster for world health. This figure is 
obviously schematic and Murray et al. (2012) have shown that past estimates provided for 
malaria cases and deaths were probably underestimated, but it is however informative.  
 
The first worldwide eradication programme was launched by the WHO in 1955. The programme 
was based on house spraying with residual insecticides, antimalarial drug treatment, and 
surveillance. However, the most malarious areas, such as tropical Africa, were excluded due to 
overwhelming difficulties (Alilio et al. 2004).2 Newly independent states in tropical Africa were 
thus relying on marginal sponsored actions (residual insecticide spraying in a few urban centers, 
or larviciding in limited areas), national health systems and national malaria control programmes 
already operational by the 1950s, hospitals and dispensaries-based antimalarial activities, mass 
drug administration and availability of antimalarial drugs in the open market. The extensive use 
of residual insecticide dichloro-diphenyl-trichloroethane (DDT) and chloroquine (CQ)3 did 
benefit to Africa as overall malaria-related deaths in Africa showed evidence of decline from the 
1950s to 1980s. However, these activities may have promoted the development of both drug and 
insecticide resistance. 
                                                
2 A full history of malaria control programmes in Africa can be found in Carter and Mendis (2002) and Alilio et al. 
(2004).  
3 A drug used for the treatment and prevention of malaria, discovered in 1934 and established as an effective and 
safe antimalarial in 1946. 
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FIGURE 1: Schematic overview of Malaria control 1900‒2010 
 
Source: Authors, based on Carter and Mendis (2002); Alilio et al. (2004); Murray et al. (2012); and RBM (2013). 
 
Indeed, the downward trend in malaria-related mortality appears to have reversed in the 1970s 
due to CQ resistance and the small effect of residual insecticide DDT in SSA. Conversely, Asian 
malaria transmission was much more sensible to vector control measures using DDT because of 
the lower intensity of this transmission, a relative organizational and political stability after the 
Second World War, and the massive investment made by the WHO and bi-lateral assistance. CQ 
was the main malaria therapy worldwide from the 1940s until the 1990s and Africa is highly 
vulnerable to the continuing availability of effective antimalarial drugs. That is why preserving 
drugs’ effectiveness is essential. Following the emergence of CQ-resistant Plasmodium falciparum, 
most African countries discontinued the use of CQ, and now promote ACT as the first-line 
treatment. This change was generally initiated during the last decade in West and Central Africa 
(Gharbi et al. 2013). Indeed, in the late 90s, the Chinese drug artemisinin has been hailed as one 
of the greatest advances in fighting malaria, since the discovery of quinine centuries ago. 
Artemisinin was first extracted by the Chinese in 1971 from Artemisia Annua. This treatment was 
not new (Klayman 1985) but the first ACTs were provided at reduced prices to the WHO only 
in 2001. Approximately at the same time, in 1998, the WHO launched a second campaign aiming 
to halve malaria deaths worldwide by 2010 (Nabarro and Tayler 1998). The Global Fund (GF) to 
Fight AIDS, Tuberculosis and Malaria was created in 2002, and soon after its founding, became 
the main multi-lateral funder in the global health arena.  
 
Nowadays, the primary objective of these new malaria control campaigns is to reduce deaths and 
illness from the disease. Elimination of infection is far more difficult. The policies and strategies 
for malaria control are based on LLINs and ACT, plus a revival of support for indoor residual 
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spraying of insecticide (IRS). The combination of these actions has several advantages. First, 
ITNs are comparable to measles vaccination in their cost-effectiveness in preventing malaria 
deaths and morbidity and can be used for mosquitoes control and as a preventive measure. 
Second, the demise of CQ and sulfadoxine-pyrimethamine leaves ACT as the best treatment 
option. The advantages of ACTs (easy to administer, few side-effects, rapid action against the 
parasite, increase in the efficacy of both drugs) are widely recognized. In addition, patients given 
two or more effective drugs are less likely to encounter drug resistance and failed treatment, 
because parasite mutations to both components with different mechanisms of action are less 
probable. Currently there are six ACTs approved by regulatory authorities (Lin et al. 2010).4 
Third, IRS is the application of insecticides to the inner surfaces of dwellings, where endophilic 
Anopheline mosquitoes often rest after taking a blood meal. According to WHO, several years of 
consecutive rounds of IRS are effective in reducing malaria parasite prevalence and incidence in 
areas of high transmission and can be used in combination with ITNs5. Last, Seasonal Malaria 
Chemoprevention (SMC) is recommended by the WHO in parts of the world where malaria is 
seasonal, such as the Sahel sub-region of Africa. Most childhood malaria mortality and morbidity 
occurs during the rainy season in these regions. The provision of effective malaria treatment at 
intervals during this period has been shown to prevent illness and death from malaria among 
children.6 
 
2.2 The ‘value for money’ of malaria control programmes 
Growing value for money agenda aims to reduce costs, increase impact per US$ spent, and focus 
investments on the highest impact interventions among the most affected populations (Fan et al. 
2013; Glassman et al. 2013). 
 
This agenda is all the more relevant as, according to the 2012 Malaria Report (WHO 2012), the 
past decade has witnessed tremendous expansion in the financing and implementation of malaria 
control programmes. International disbursements for malaria control rose steeply from less than 
US$100 million in 2000 to US$1.71 billion in 2010, and were estimated to be US$1.66 billion in 
2011 and US$1.84 billion in 2012. Analysis indicates that as funding has risen, international 
disbursements have been increasingly targeted to the African region (contrary to the first WHO 
campaign), to countries with the lowest gross national income (GNI) per capita, and to countries 
with the highest malaria mortality rates. Domestic government funding for malaria control 
programmes also increased through 2005–11, and was estimated at US$625 million in 2011.  
 
The paradigm shift from malaria control to malaria eradication following declarations at the 
Gates Malaria Forum in October 2007 and subsequent support voiced by WHO, the Board of 
the Roll Back Malaria (RBM) Partnership, the United Nations (UN) Secretary-General in 2011, 
and many other institutions has renewed inspiration for innovation and public health action. The 
GF remains the largest source of funding for malaria control globally, accounting for 39 per cent 
of estimated disbursed funds in 2011 and 40 per cent in 2012 (WHO 2012). The second and 
third largest funders are the President’s Malaria Initiative and the World Bank’s Booster 
programme. However, while there have been substantial increases in funding for malaria control, 
they continue to fall short of the amount needed to achieve the global goals. The Global Malaria 
                                                
4 Artemether-lumefantrine; artesunate-amodiaquine; artesunate-mefloquine; artesunate-sulfadoxine-pyrimethamine; 
dihydroartemisinin-piperaquine; and artesunate-pyronaridine. 
5 See Mabaso et al. (2004) for a historical review of malarial control in southern African with emphasis on the use of 
IRS. 
6 WHO recommends SMC with sulfadoxine-pyrimethamine and amodiaquine in areas with highly seasonal malaria 
transmission in the Sahel sub-region of SSA, where P. falciparum is sensitive to both antimalarial medicines. 
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Action Plan (RBM 2013) estimates that US$2.196 billion will be needed annually in 2015 to 
scale-up preventive and curative interventions to reach universal coverage in Africa. 
 
In the past decade, a trend has appeared in malaria-induced mortality, with decreasing mortality 
around 2005 (Figure 1, and Murray et al. 2012). It is however difficult to assert a direct causal 
relationship of all malaria control policies because limited rigorous evaluations have been 
undertaken. It is possible that this favourable trend is mainly due to the spread of ACTs alone.7 
However, attribution of this recent favourable trend to any of the policies that have been 
implemented is impossible due to the lack of measurement instruments and formal external large 
scale impact evaluations for interventions and service delivery strategies (Fan et al. 2013). 
Randomized studies are needed to assess the efficiency of such programmes and optimal 
combinations of actions from a supply side perspective.  
 
Moreover, we have factual indications that a number of specific initiatives have had moderate 
positive or negative impact. First, subsidizing treatment may increase their usage among people 
who do not actually have malaria. Cohen et al. (2011) shows that only 25 percent of adults (over 
age 18) who purchased subsidized ACTs at drug shops were tested malaria positive. Second, as 
shown by Laxminarayan et al. (2010), at extremely high infection transmission rates (in excess of 
about 70 infectious bites per year), treatment subsidies may be inefficient because recovering 
individuals quickly become re-infected so that there is little impact on reducing the size of the 
infected population. Third, surveillance systems and research studies supported by WHO to 
monitor antimalarial drugs’ efficacy in countries do provide evidence that parasites resistant to 
artemisinin have emerged along the border between Cambodia and Thailand.  
 
In addition, proliferation of insecticide resistance suggests that the spread of insecticide 
resistance is a major threat for vector control programmes, especially pyrethroid resistance in 
Africa (Santolamazza et al. 2008). Currently, insecticides used for IRS come from only four 
classes: pyrethroids (the most commonly used class); organochlorines (of which DDT is the only 
compound in use); organophosphates; and carbamates; all WHO-recommended. ITNs and 
LLINs use pyrethroids. As malaria vector control, and consequently the success of global malaria 
control, is heavily reliant on a single class of insecticide, the pyrethroids, increasing resistance of 
malaria vectors to pyrethroids and to other insecticides jeopardizes global malaria control efforts.  
 
Apart from technical considerations, the analysis of demand and supply chain of malaria control 
tools suggests a number of difficulties that may affect the effectiveness of policies that are 
currently implemented. 
 
2.3 Demand and supply chain 
Amongst potential explanations of a potential limited effect of malaria control, a number of 
different demand and supply side factors can influence malaria prevention and treatment. On the 
demand side, financial constraints are the main reasons given by households for not acquiring 
health products (Guyatt et al. 2002; Bates et al. 2004a, 2004b; Wiseman et al. 2007; Eisele et al. 
2009; Afolabi et al. 2009; Krezanoski et al. 2010). Indeed, demand for these products appears 
quite price elastic. In Kenya, Cohen and Dupas (2008) found that pregnant women universally 
                                                
7 Unfortunately, until now, the Global Price Reporting Mechanism (GPRM) hosted by the WHO website (a 
database recording international transactions of HIV, tuberculosis and malaria commodities purchased by national 
programmes in low- and middle-income countries) does not provide free access to the data on anti-malaria 
medicines. 
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take up an antimalarial bed net when it is given for free during a prenatal visit, but only 40 per 
cent buy one at the still highly subsidized price of US$0.60. Understanding this peculiar 
behaviour and its consequences for malaria control requires building an economic-
epidemiological model (see Section 4). In addition, bed net coverage remains inequitable among 
different socio-economic groups: higher income household are much more likely to possess a 
bed net (Matovu et al. 2009; Ye et al. 2012; García-Basteiro et al. 2011). However Onwujekwe et 
al. (2004) showed that demand for bed nets increases with income but less than proportionally. 
Lastly, Tarozzi et al. (2011) highlight the role of liquidity constraints in explaining low adoption 
rates. 
 
On the supply side, health centres, dispensaries, and hospitals deliver different types of medical 
activities: curative and preventive healthcare services, in addition to daily health education, which 
are characterized by different production processes. The literature on the efficiency of healthcare 
systems in developing countries generally focuses on hospital level data or other aggregated data 
(health center, health district, regional or national levels). Patient level data or household data are 
generally less used for this specific purpose. Nevertheless, the choices people make vary 
considerably across Africa, depending on the type of delivery strategies that operate in that area. 
For instance, lack of availability and failure in ITN distribution systems have been identified by 
RBM as the main limitations (other than cost) of large-scale implementation of ITN use. 
Cumulative attrition across the different steps of distribution programmes, or small failures in 
the distribution process result in people dropping out of the system (Marchant et al. 2010). In a 
literature review of 127 reports and studies, Kilian et al. (2010) found that community-based 
distribution campaigns achieve rapid increases in bed net coverage, but this coverage fluctuates 
after a few years. Continuous distribution mechanisms (routine services, retail outlets, assisted or 
unassisted commercial markets) avoid these fluctuations but are much slower in building-up high 
coverage levels.8 
 
Continuous promotion of effective maintenance and routine healthcare education is also needed 
and efforts to replace damaged nets must be implemented (Githinji et al. 2010). However, many 
of these strategies have not been assessed to date and only some of the existing cost-estimates 
have been derived using appropriate methods (Kolaczinski et al. 2010). Seban et al. (2013) use a 
household survey conducted in 2009 in Haut Katanga, Democratic Republic of Congo (DRC). 
They combine these data with estimates on malaria prevalence from the Malaria Atlas project. 
Results show that households behave rationally with respect to the disease. They also show that 
health centers are not the most effective in promoting possession of bed nets, in areas where 
they are most needed for malaria control. The governments of malaria-endemic countries often 
lack financial resources. As a consequence, health workers in the public sector are often 
underpaid and overworked. They lack equipment, drugs, training, and supervision. The local 
populations are aware of such situations when they occur, and cease relying on the public sector 
health facilities. Conversely, the private sector suffers from its own problems. Regulatory 
measures often do not exist or are not enforced. This encourages private consultations by 
unlicensed, costly health providers, and the anarchic prescription and sale of drugs (some of 
which are counterfeit products). Correcting this situation is a tremendous challenge that must be 
addressed if malaria control is to be successful. 
 
                                                
8 Other reviews can be found in Stevens (2005); Hill et al. (2006); and Lengeler et al. (2007). Other studies analyse 
different delivery strategies and the cost-effectiveness of ITN/LLINs (Thomson et al. 1995; Goodman et al. 1999; 
Chima et al. 2003; Morel et al. 2005, Worrall et al., 2005, Chuma et al., 2006). For a literature survey of studies 
assessing the economic burden of malaria since 1909, see Packard (2009). 
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3 Economic impact of malaria in Africa 
If it is possible to analyse the causal effect of a programme, it is probably more difficult to 
analyse the causal effect of poor health on economic outcomes. This is also true for malaria. In 
economic terms, the total household cost burden of malaria is estimated to be high in Africa. 
Early estimates of total costs (Shepard et al. 1991) reported that the total cost of malaria for SSA 
was 0.6 per cent of total SSA GDP in 1987 and one per cent in 1995. At the household level, 
Worrall et al. (2005) provide an exhaustive literature survey and find mixed evidence on the 
effects of socio-economic status (probably due to endogeneity bias) on malaria incidence but 
find strong evidence that malaria prevention and treatment is related to socio-economic status.  
 
3.1 Malaria, poverty, and growth: a circular relationship? 
The neoclassical approach 
In a neoclassical context, the impact of malaria on income per capita at the steady state will be 
theoretically undetermined: lower population growth rate leading to higher income per capita by 
reducing demographic pressure on savings (positive Malthusian effect), lower savings rate 
(because of a high healthcare expenditure and because the increase in the risk of dying reinforces 
the preference for the present) and therefore lower per capita product (negative effect), lower 
labour productivity (absenteeism, fatigue) entailing in a reduction in per capita output (negative 
effect).  
 
Barlow (1967) examined the economic effects of malaria taking into account the multiplicity of 
these effects and integrating general equilibrium effects in a macroeconomic demographic 
model. He identified four effects of malaria eradication on per capita income: effects on 
population size (increase in population resulting from both declining mortality and rising 
fertility), effects on labour inputs (increase in labour supply and efficiency); effects on capital 
inputs (limited and unproductive private saving due to population growth and public 
investments); effects on output (exploitation of new territories). In his calibrated model, Barlow 
found a positive impact of malaria eradication in the short run and a negative impact in the long 
run in Ceylon between 1947 and 1965. Eradication led to immediate increase in labour quality 
and quantity (through reductions in morbidity and debility and decreased mortality). This 
increases income per equivalent consumer. After a while (1953‒55), the negative effects of 
malaria eradication became prominent (increased population, decreased savings, higher demand 
on the public sector). In his model, the main economic disadvantage of a malaria-eradication 
programme is the rapid increase in the population of children. He suggested that these effects 
could be contained by birth control. However, Barlow’s model is not without limits.  
 
Following Newman’s (1970) findings, Barlow (1967) supposes that malaria eradication will raise 
fertility, but the demographic effects of malaria are theoretically undetermined. Malaria can have 
three short-term effects on fertility (Lucas 2013): 1) a negative biological effect on fecundity; 2) 
economic theories predict that increased income and the decreased price of a surviving child will 
increase fertility (positive effect); 3) the demographic transition theories suggest that increased 
survival certainty and preferences for quality over quantity will decrease fertility (negative effect). 
There are two long-term demographic effects of malaria eradication on fertility: 1) women born 
after eradication will be healthier, leading to higher fertility; 2) if malaria has a negative effect on 
education, their additional education increases their opportunity cost of time, potentially 
lowering total fertility. For instance, Lucas (2013) finds that the initial effect of malaria 
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eradication in Sri-Lanka (1937‒53) was actually an increase in fertility (because of the biological 
effect) but the next generation had lower fertility and higher education. Therefore, while the 
initial population growth might be detrimental to gross domestic product GDP per capita, 
increased education and lower subsequent fertility can mitigate this initial negative growth effect. 
This seems contradictory to Barlow’s findings. It is possible that Barlow’s long run was 
insufficiently long. Another controversial aspect of Barlow’s (1967) hypotheses is that he 
considers that the malaria eradication will ‘impose burdens on the educational sector’ due to the 
massive enrolment of new cohorts of children as time progresses. Investments in health are not 
supposed to improve the quality of the workforce through children’s human capital 
accumulation in his model, while the influence of malaria on cognitive capacity of the children is 
now relatively well documented (see below). 
 
3.2 Empirical studies on the macroeconomic effects of Malaria 
A series of papers have explored the link between economic development and malaria.9 Contrary 
to other tropical diseases and since the failure of eradication efforts in the 1980s, malaria has 
been described as an unavoidable effect of tropical location and natural forces (i.e., heavy rains, 
floods).  
 
Gallup and Sachs (2000), using a malaria exposure index defined as the fraction of population at 
risk of contracting falciparum malaria in a country, show that poverty is not a leading cause of 
malaria, ceteris paribus. In a cross-country regression framework, the authors find that countries 
with intensive malaria are poorer and have grown 1.3 per cent less per person per year. These 
results point to malaria’s causing poverty, not vice versa. 
 
In another article, McCarthy et al. (2000), using estimates of malaria morbidity from the WHO, 
suggest that economic development may influence malaria control. They confirm the dominant 
role of climate in determining malaria intensity and the negative correlation between malaria and 
growth but they find that access to rural healthcare and income equality also influence malaria 
morbidity once one controls for climate. This finding raises the problem of the endogeneity of 
malaria with respect to growth and the robustness of the results in this field of research.  
 
In contrast, in Acemoglu et al. (2003a), malaria ‘is unlikely to be the reason why many countries 
in Africa and Asia are very poor today’. More generally, Acemoglu and Johnson (2007) also cast 
doubt on the causal relationship between bad health conditions and poverty. 
 
It is now clear that Gallup and Sachs (2001) or McCarthy et al. (2000) studies did not prove that 
malaria is a cause of low incomes and poor economic growth. Many other changes occurred 
simultaneously in the economies where malaria has been eliminated. Malaria eradication can be 
correlated with many other factors that influence economic growth including governance and the 
quality of public policies that have been omitted from econometric models. Packard (2009) notes 
that ‘given the multiple difficulties associated with past efforts to demonstrate the impact of 
malaria on economic development and the economic benefits of malaria control, it is surprising 
that Gallup and Sachs stated their conclusions with such confidence and that their conclusions 
have been accepted with so little question.’  
 
                                                
9 See for instance McDonald (1950); Barlow (1967); Newman (1968); Gomes (1993); Audibert et al. (1999); and 
Bowden et al. (2008).  
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However, the terrible toll on the health and well-being of people living in malaria-endemic or 
epidemic areas and the convergence between different studies10 prove at least that the disease 
could be considered a potential legitimate contributor of poor economic performance (Arrow 
2004). The macroeconomic literature is relatively poor compared to the microeconomic literature 
on malaria. Although macroeconomic effects are not the mere aggregate of microeconomic 
results, it seems legitimate that, in the absence of reliable aggregate data on malaria and of 
relevant macroeconomic instruments, that would help to solve the endogeneity issue, most of 
the recent research on this topic takes a microeconomic orientation.  
 
3.3 Cost analysis of malaria in Africa: direct, indirect, and opportunity costs 
The human capital approach 
To disentangle the relationship between malaria and poverty we need to establish an accurate 
account of the costs of malaria. Microeconomic studies on malaria mostly use the human capital 
approach. This approach leads one to estimate the costs of malaria on various levels: those 
incurred by individuals and households, public health services and governments, and other 
private agents (firms, non-governmental institutions for instance). Direct or immediate costs are 
distinguished from indirect costs.  
 
Direct costs on household and individual level are expenditures related to prevention and 
treatment. Seeking treatments at health centers, buying drugs, and arranging funerals entail 
obvious financial costs. For the private business sector, the cost of private healthcare provided 
by employers may rise. For public health services, public expenditures for malaria prevention and 
treatment may be substantial even if they are not easily quantified. This lack of quantification can 
result in a reduction in the standard of care for all patients.  
 
Indirect costs include, among others, lost time due to illness (such as time spent seeking care), 
long-term losses in household productivity and income, absenteeism from work or school, 
decline in activity in various sectors, and excessive use of government resources on related 
expenditures. Studies on the indirect cost vary widely in their methods and in what they try to 
assess.  
 
Opportunity costs are the costs of spending time and effort to avoid the disease rather than 
using these resources for an economically productive activity, or the cost equal to what an 
individual must give up in order to avoid or cure malaria. 
Specific channels through education and productivity  
One area where malaria may have a detrimental effect on economic growth is its impact on the 
health and mental development of children. For instance, Thuilliez (2010a, 2010b) shows that 
the relationship between school results (measured by class repeat and completion rates) and P. 
falciparum malaria is strong at the macroeconomic and community levels. There are a number of 
ways through which malaria can impact children's educational achievement, even if the precise 
medical mechanisms for the effects of malaria on education and learning remain unknown.11 
 
                                                
10 See for instance Shepard et al. (1991) and Chima et al. (2003). 
11 Thuilliez et al. (2010) provides a detailed discussion on potential mechanisms involved in this relationship. 
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First, because of depressed acquired immunity during pregnancy, malaria is a real threat for both 
pregnant women and the foetus. Indeed, malaria can lead to anaemia, increased risk of premature 
delivery, low birth weight and foetal growth retardation, which may translate into cognitive, 
physical or development impairments. Barreca (2010) analyses the long-term economic impact of 
in utero and postnatal exposure to malaria and finds substantial effects on educational attainment 
in adulthood. 
 
Second, among children under the age of five, complicated forms of malaria may develop 
rapidly. The effects of severe malaria, better known as cerebral malaria (CM), have been 
quantified by numerous studies.12 For instance, Ngoungou et al. (2007) provide a quantification 
of the burden in Mali. 101 subjects (mean age was 5.6±3.6 years) who had had CM in Mali were 
followed from 1999 to 2001. The authors find that 28 children presented persistent neurological 
sequelae (26.7 per cent). Among them, eight (7.9 per cent) children had developed these sequelae 
just after CM and 20 (19.8 per cent) a few months later. These included headaches, mental 
retardation, speech delay, bucco-facial dyspraxia, diplegia and frontal syndrome (one case each), 
dystonia (two cases), epilepsy (five cases), and behaviour and attention disorders (15 cases). This 
study shows that neurological signs due to CM can persist in the long run (or at least a few 
months after). Many other studies have analysed the relationship between severe falciparum 
malaria and developmental and long-term cognitive impairment (Carter et al. 2005; Boivin et al. 
2007; John et al. 2008).  
 
Third, even during late childhood (which usually extends from six to 16 years of age), the 
protection conferred by acquired immunity is only partial. If CM is rare at this stage, 
uncomplicated malaria, repeated illness, or chronic malaria infections are not. They can have a 
non-cognitive impact on educational achievement through school absenteeism, general health 
conditions, and investment in curative strategies (coping strategies against the disease detrimental 
to educational investments). For instance in a Kenyan case study, Brooker et al. (2000) attribute 
13‒50 per cent of medically related school absences to malaria. In Kenya, primary school 
students were determined to miss 11 per cent of the school year (20 school days missed per 
child/year). In Nigeria, school days missed varied between two per cent to six per cent of the 
school year (three to 12 days per year per student). In Mali, malaria was the primary cause of 
absenteeism during a full school year (Thuilliez et al. 2010). Moreover, although the age 
distribution of uncomplicated malaria and asymptomatic malaria depends on transmission 
intensity, the total burden of disease may be similar or even higher in settings of low 
transmission due to patterns of acquired immunity. Malaria morbidity among school-age children 
increases as transmission intensity decreases, but asymptomatic infections are more frequent in 
high-transmission settings (Clarke et al. 2004; Dicko et al. 2007). Fernando et al. (2003) show a 
significant negative correlation between the total number of malarial attacks experienced by 
children and test scores during a six year follow-up. Fernando et al. (2006) and Jukes et al. (2009) 
also show a substantial effect of preventive treatment in two randomized studies. Yet, 
asymptomatic malaria has proven to have detrimental effects on children’s cognitive and 
educational skills in three studies, one being a cluster-randomized control trial which suggests 
either a direct causal effect of the disease or an antimalarial treatment effect (Clarke et al. 2008; 
Thuilliez et al. 2010; Nankabirwa et al. 2013), although confirmatory studies are needed. The 
mechanism could include a ‘toxicity effect, leading to biochemical changes in the central nervous 
system (CNS); excitation of the immune system, leading to changes in behaviours related to 
appetite and reaction time; and physiological effects such as discomfort and disturbed sleep, 
leading to reductions in activity levels or causing behavioural change’ (Holding and Snow 2001). 
 
                                                
12 A literature review (1960‒2002) can be found in Mung’Ala-Odera et al. (2004). 
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Another area where malaria may have a detrimental effect on economic growth is its impact on 
productivity. The effect of malaria on farmers’ productivity and efficiency has been the subject 
of careful research (Conly 1975; Audibert et al. 1990, 1999, 2003, 2009; Leighton and Foster 
1993). The results from Audibert et al. (2009) suggest that the effect depends on the type of 
agricultural activity. Indeed malaria has no effect on coffee and cocoa productions but reduces 
technical efficiency in the cultivation of cotton. One difficulty tackled in later articles on 
efficiency relates to coping or anticipatory coping strategies adopted by the families (particularly 
wealthy families) that bias the estimated effects of the disease on production and productivity. 
The size and direction of this bias depends on the conditions of the labour market and on 
epidemiologic conditions. Other difficulties come from measurement errors related to health 
variables, omitted variables or reverse causality leading to endogeneity problems (Strauss 1986). 
This difficulty suggests the necessity to measure malaria on a very thin scale as the morbidity 
effects on productivity are often measured imperfectly. Notably asymptomatic malaria in intense 
transmission area probably has little effects on agricultural productivity as individuals are not 
strongly invalidated physically.  
Natural experiments  
Natural experiments do not analyse the direct effect of the disease but provide estimates of the 
effects of interventions in real world context, in complement to randomized trials used for 
evaluation in experimental context (already mentioned in Section 2). In a recent paper with a 
historical perspective, Bleakley (2010) considers the malaria-eradication campaigns in the United 
States (1920), Brazil, Colombia and Mexico (1950) to assess the impact of childhood exposure to 
malaria on labour productivity. Using a cohort-level dataset based on microeconomic data, 
Bleakley finds that cohorts born after eradication enjoyed higher levels of income and literacy as 
adult than the preceding generation. In India, Cutler et al. (2010), using a similar quasi-
experimental framework, find modest increases in income levels for men but not for women and 
no evidence of increased educational attainment for men but mixed evidence for women. Lastly, 
one limitation of these studies is that they use data from the ‘malaria periphery’, defined by Lucas 
(2010) as areas in which malaria transmission was primarily seasonal or epidemic before 
eradication. These countries have particular epidemiological settings and were classified as P. 
vivax-dominant areas before eradication campaigns. Thus, they are generally unaffected by the 
most severe P.falciparum malaria, and the external validity is limited to these areas. In Africa, 
Kuecken et al. (2013) examine the medium-term effects of the GF’s malaria control programmes 
on the educational attainment of primary schoolchildren in SSA using a quasi-experimental 
approach. In the majority of countries (14 of 22), they find that the programme led to substantial 
increases in years of schooling and grade level as well as reductions in schooling delay. 
 
Mosquito vectors have often been seen as promise to solve malaria endogeneity problem in 
economic studies. For instance, this line of arguments has first been used for cross-country 
analysis by Sachs (2003) or recently by Bleakley (2010). The latter uses a malaria ecology index as 
an instrumental variable for malaria prevalence at a county level. Biological properties of 
regionally dominant malaria vectors (longevity and human-biting habit) and thus the force of 
infection, is said to be exogenous to public interventions and economic conditions (Kiszewski et 
al. 2004). Even if many authors doubted the exogeneity of malaria ecology at the macroeconomic 
level (Rodrik et al. 2004; Acemoglu et al. 2003a, 2003b), Bhattacharyya (2009) as well as 
Carstensen and Gundlach (2006) claimed that these doubts may not be justified because the 
region-specific dominant malaria vector reflects only the forces of biological evolution. 
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4 Malaria economic epidemiology  
4.1 Fees and behavioural factors  
Bates et al. (2012) provides a literature review of randomized experiments on price-elasticity of 
health products, including malaria specific measures. The results show that charging small fees in 
an attempt to balance access and ‘sustainability’ may not be a good solution, as relative to free 
distribution, charging even very small user fees substantially reduces adoption, i.e., charging does 
not encourage use. Behavioural obstacles to efficient control and/or eradication of malaria also 
appear to have been underestimated. ITNs have reduced malaria transmission and child 
morbidity in short-term trials. However, as shown by various papers (Rhee et al. 2005; Toé et al. 
2009), even in experimental contexts in small communities where education on malaria and use 
of nets was given before net distribution, the proportion of households that used the nets 
remained low. Use also tended to decrease a few months after the programme. Studies in 
Burkina Faso (Toé et al. 2009) and Madagascar (Krezanoski et al. 2010) revealed that there was a 
high rate of ITN use for the first few months but that the rate of use subsequently fell for 
apparently non-objective reasons. This could be due to motivation (Toé et al. 2009), seasonal 
factors because people stopped using nets when mosquitoes were less noticeable (Baume and 
Marin 2007), individual perception and room organization (Toé et al. 2009). Toé et al. also 
stressed that there had been very few evaluations of the short- and long-term impact of 
motivation campaigns. Their study showed that ‘LLINs were not used when the perceived 
benefits of reduction in mosquito nuisance and of malaria were considered not to be worth the 
inconvenience of daily use.’ Marchant et al. (2010) also suggested that there might be additional 
barriers to using an insecticide-treated net, especially among the poor. ‘Providing incentives for 
behaviour change is a promising tool that can complement traditional ITN distribution 
programmes and improve the effectiveness of ITN programmes in protecting vulnerable 
populations’ (Krezanoski et al. 2010).  
 
Berthélemy et al. (2010) provide a theoretical argument to explain such results by economically 
rational behaviours. When integrated into a dynamical framework this analysis allows for an 
explanation of the probable endogenous relationship between malaria and poverty, leading to a 
malaria-related poverty trap, and an integration of possible externalities.  
 
4.2 Is there a malaria-related poverty trap? 
This section proposes a model for malaria economic analysis by combining economic 
epidemiology tools with the literature on poverty traps (the full model being provided in 
Berthélemy et al. 2013). A theoretical model of rational protective behaviour in response to 
malaria is designed, which includes endogenous externalities and disease characteristics. 
 
A standard epidemiological model of malaria was built, with transmission of malaria between a 
population of humans and a population of mosquitoes (Smith and McKenzie 2004). Simplifying 
assumptions have been assumed: constant population sizes (human and mosquito) over time, 
uniform contacts between human and mosquitoes, ignorance of superinfection and immunity. 
Within the life-time period of humans, malaria prevalence among humans and mosquitoes 
reaches a steady state. This leads, in absence of protection, to equations based on the McDonald 
and Ross malaria transmission model (Smith and McKenzie 2004).  
 
The time variation of malaria prevalence among humans can be defined in a simplified way as: 
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 (1) 
 
where m is the vector density (ratio of mosquitoes per human), a is the number of bits per unit 
of time and per mosquito, b is the proportion of infected bites that produce infection among 
humans, Z is the proportion of infectious mosquitoes, and r is the clearance rate of malaria in 
humans. 
 
Similarly, the variation of the proportion of infectious mosquitoes can be written as: 
 
  (2) 
 
where c is the proportion of bites on infectious humans that produce infection among 
mosquitoes, g is the death rate of mosquitoes, and n is the length of sporogonic cycle. 
 
Assuming that the time period of life is long enough, malaria prevalence reaches a steady state 
equilibrium defined by a function Q(X, m), which depends on all parameters defined in 
Equations (1) and (2) (see Berthélemy et al. 2013).  
 
This function is concave, and characterized by the following properties: 
 
  
 
And its slope at origin is equal to a number, R0, that is classically called in the MacDonald (1950, 
1957) and Ross tradition the ‘basic reproduction rate’. If  R0 is below or equal to 1, then Q(X,m) 
converges towards the trivial disease free stable steady state. This case is not considered in what 
follows, as it does not coincide with the persistence of malaria in large regions of the developing 
world. Conversely, if R0 is higher than 1, then Q(X,m) converges towards a stable steady state 
characterized by a strictly positive prevalence of malaria.  
 
4.3 Economic epidemiological model with protection 
When the basic reproduction number R0 is higher than 1, using protection tools could 
nevertheless reduce malaria transmission, and then, the trivial disease free stable steady state 
could be reached. This is the rationale of ITN/LLINs dissemination policies. In order to assess 
this possibility, a model of protection behaviour has been added to the previous epidemiological 
model. This behavioural model, as described below, is based on economic mechanisms. Peoples 
adopt certain behaviours: use of an insecticide-treated net ( ) or exposure to malaria risk 
( ). It is supposed that the only means by which a person can prevent himself from 
parasitic infection is to sleep under an ITN/LLIN (even if a person can be infected during the 
first part of the night). As a first assumption, the use of an ITN/LLIN was supposed to provide 
complete protection from malaria infection. This assumption can be relaxed without affecting 
the main findings of the model (Berthélemy et al. 2013). At any time, depending on the use of 
ITN before, the health status of the individual,  can take one of two values: susceptible, 
, or infected, . The probability of being infected at any time, conditionally to 
the absence of protection before, can then be written as: 
 
  (3) 
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and this probability πI is equal to the value of the Q(X,m) function defined in the 
epidemiological model in absence of protection. 
 
If  is the proportion of population using ITN/LLIN, among the (1-X) uninfected persons, the 
proportion of infected persons can be simply written as: 
 
  (4) 
 
Furthermore the density of mosquitoes in contact to humans, m, is affected by the presence of 
ITN/LLIN used by a proportion H of the population. First, as the contact between mosquito 
and human is more difficult, the denominator of the mosquito density decreases, being now the 
proportion 1-H of non-protected population. Second, as ITN/LLINs do not only protect 
humans, from anopheles bites, but also kill mosquitoes (knock down effect), the numerator (the 
number of mosquitoes) decreases with H. Hence m, which was a parameter in the pure 
epidemiological model, can be now written as a function of H as follows: 
 
  (5) 
 
Where γ(H) is the proportion of mosquitoes killed by the use of ITN/LLINs, an increasing 
function of H.  
 
It follows that, at the steady state: 
 
 (6) 
 
In order to complete the model, the determinants of H were specified in a next step. At the 
microeconomic level, the choice of protection is determined by maximizing the expected utility 
of each individual. The decision h of protection (h=1 for protection, h=0 for non-protection) 
affects individuals’ utility through two channels: (i) an expected positive impact on their health 
status in case of protection and (ii) a private cost, called κ. Hence protection decision is described 
through the following maximization programme: 
 
 (7) 
 
Where  or  are the utility levels attached to the health status (susceptible, , or 
infected, , thus depending on , the use of a protection), with ;  is 
the individual income;  is the marginal utility of the income , supposed as usual to 
decrease with income.  
 
The expected utility (the expected positive impact of using ITN/LLIN on the health status) can 
be estimated using the following probabilities of being susceptible or infected, conditionally to 
the use of protection: 
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In addition, it is assumed that there exists a minimum subsistence level, such as in the case a 
Stone-Geary utility function. This implies that the marginal utility of income W(ω) goes to 
infinity for all individuals at (or below) the minimum subsistence level, which is classically called 
the extreme poverty line Ω (i.e. the minimum level of income deemed adequate in a given 
country for an individual or a household). In other words, the extreme poverty line is an income 
level below which nobody can afford an ITN/LLIN, i.e. .  
 
As in standard economic epidemiological models, the individual will use protective tools when 
 is lower than the expected utility loss associated with the risk of infection that occurs in 
the absence of protection: 
 
  (9) 
 
According to Equation 9 and the three probabilities of Equation 10 it follows that: 
 
  if and only if   (10) 
 
A person will use ITN/LLIN if the utility of being non-infected is greater than the utility of 
paying for a protective tool, according to the income and the probability of being infected 
without using any protection. Hence, protection occurs if and only if: 
 
  (8) 
 
This equation shows that there is a threshold probability of infection above which a person 
engages in protection. The key point in this approach is that the threshold probability of 
infection depends on the marginal income utility loss associated with using the ITN/LLIN, 
, with respect to the net value attached to susceptible health status, . This 
threshold depends on the individual income . The threshold function, linking  to , termed 
, is monotonic and , as the function  is monotonic and . In 
addition, the function  is increasing with . Consequently: 
 
  (92) 
 
and the income threshold conditioning protection, , decreases with . Knowing 
individual protection behaviours, the aggregated level of protection  (the percentage of 
protected persons) can be computed by integration as follows:  
 
 (10) 
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Where  is the probability density function of  (and  the associated cumulative density 
function), describing the income distribution of the population. Equations 6, 8, and 13 fully 
describes the dynamics of  and  as a function of .  
 
4.4 Prevalence-elastic behaviour at the steady-state vicinity 
Nearby the steady-state, the dynamics corresponds to a standard prevalence-elastic behaviour of 
protection (positive malaria prevalence elasticity), where H is an increasing function of X, 
because it is increasing with πI (Equations 8 and 13). Note that as a consequence, nearby the 
steady-state, X is not necessarily monotonic in πI: protection behaviours and epidemiological 
dynamics go in opposite directions. This is consistent with standard results in economic 
epidemiology.  
 
More precisely, combining Equations (6) and (15) it follows that: 
 
  (11) 
 
This equation provides us with some economic determinants of protection at individual and 
aggregated levels, that could be possibly tested (see Berthelemy et al. 2013, for tests on Ugandan 
data). For a given probability of infection in absence of protection, protection decreases with the 
unit costs of ITN/LLIN,  (through the function ). It also decreases with poverty, as the 
poorer the individuals, the higher their marginal utility of income.  
 
4.5 Long-term properties: conditions of persistence of a malaria trap 
The main question to be solved, concerning the long-term properties of this model at the steady-
state, is whether malaria can persist in the long run, in spite of the availability of ITN/LLINs as 
protection tools since the higher the unit cost κ of ITN/LLINs, the lower the protection. This is 
why ITN/LLINs programmes are usually based on subsidized ITN/LLINs prices. Let us then 
consider the best case of almost full subsidization, when κ→0 (i.e. the extreme case being free 
distribution). Conditions under which, for any positive unit cost κ, the malaria trap persists are 
given below. 
 
Proposition 
For any , when  the long term equilibrium corresponds to a persistence of malaria, if 
and  
 
only if   (12) 
 
where F(Ω) is the proportion of persons under the extreme poverty line in a population, also 
called the extreme poverty incidence. Note that m depends on H, the proportion of protected 
persons (Equation 7), which depends itself on income (Equation 13), and, thus, on the extreme 
poverty incidence. 
 
 17
Given  and , as the vector density  is a decreasing function of , the 
higher the incidence of extreme poverty , the higher the risk of persistence of malaria. 
Hence, malaria will persist for high enough values of the basic reproduction number  and of 
the extreme poverty incidence , even when ITN/LLINs are highly subsidized. In the 
extreme case where all the population is at or below the extreme poverty line, the condition 
above corresponds exactly to the basic reproduction number, and hence this policy is certainly 
ineffective as long as .  
 
One could argue that if ITN/LLINs were provided at no cost to individuals (κ=0), then all 
individuals including the extreme poor, would use them. Distribution of ITN/LLINs for free 
would then possibly be a much more efficient policy to reduce malaria, compared to selling 
ITN/LLINs at a subsidized price. This is in line with randomized experiments that found that 
free distribution dramatically increases use of ITN/LLINs (as well as other important products 
for the poor), compared to charging even very small user fees (Bates et al. 2012).  
 
Nevertheless, the assumption  is merely theoretical, even though it can be possibly 
obtained in controlled experiments, as in practice  is not only the price of ITN/LLINs: It 
involves also all opportunity costs attached to using them for other productive activities. Selling, 
exchanging, discarding, or re-using the material from ITN/LLINs is not uncommon. For 
instance, misuse of ITN/LLINs for profit (drying fish and fishing) has been observed by Lake 
Victoria (Minakawa et al. 2008) and in Zambia (Hopkin 2008). In some cases, nets have even 
been turned into wedding dresses and water filters.  
 
Two important conclusions emerge from the model. First, agents increase their protective 
behaviour when malaria is more prevalent in a society. This is consistent with the literature on 
‘prevalence-elastic behaviour’. Second, a malaria-related poverty trap defined as the result of 
malaria reinforcing poverty while poverty reduces the ability to deal with malaria can theoretically 
exist and the conditions of existence of this trap are identified. Typically it can be observed when 
the incidence of extreme poverty is initially very high.  
 
Survey data available for Uganda provide empirical support to the theory of prevalence-elastic 
protection behaviours, once endogeneity issues related to epidemiology and poverty are solved 
(Berthélemy et al. 2013), and to the possibility of a malaria-related poverty trap. 
 
5 Conclusions 
Malaria is a major disease in SSA, which imposes a heavy human and economic toll on this 
region. Some of the first analyses on the cost of malaria, which attributed a very large economic 
cost to this disease, went probably too far in attributing a significant part of the African 
economic difficulties to malaria. Careful considerations on the bi-directional causality between 
malaria and poverty or aggregate underdevelopment suggest that the cost of malaria have been 
initially overestimated.  
 
Nevertheless, such cost cannot be neglected, and policies to control malaria have received more 
and more attention in the past decade from the development aid community, notably through 
initiatives funded by the GF.  
 
These policies, combining subsidization of new ACT treatments and the dissemination of 
protection/eradication tools, such as ITN/LLINs and IRS, have been coincidental with a recent 
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trend of reduction of malaria mortality in Africa. These policies are, however, not without 
difficulties and attributing the small successes observed recently to such policies, or identifying 
the right mix of policy instruments, are extremely difficult. 
 
As for ACTs, the risk of fast-developing drug-resistance cannot be averted. From a policy point 
of view, Laxminarayan et al. (2010) have shown in this context the limits of policy of 
subsidization of ACTs . 
 
As for ITN/LLINs and IRS dissemination, there are also risks of development of resistance to 
insecticides. Nevertheless, ITN/LLINs are still considered as technically efficient protection 
tools. In spite of this, the dissemination of ITN/LLINs is very far from satisfactory across the 
African continent. Beyond possible shortcomings in the supply chain, we point here to another 
possible difficulty, on the demand side. We have developed an epidemiologic-economic model in 
which the demand for ITN/LLINs is prevalent-elastic, which in turn leads to situations where 
the objective of malaria eradication may be out of reach. In particular, we show that in a context 
of a large extreme poverty incidence, the demand for ITN/LLINS may be too low to allow for 
complete malaria eradication.  
 
Given these difficulties, the optimal strategy is probably a combination of the different tools. 
However, more analytical work, combining epidemiological and economic models, and more 
large-scale impact evaluations of the policies that have been implemented, are needed to make 
progresses in the identification of the right strategy. Given the heavy toll of malaria in Africa, this 
agenda of research should be given a high priority by economists and epidemiologists. 
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